1.
J Hasford, M Pfirrmann, P Shepherd, J Guilhot, R Hehlmann, FX Mahon, HC Kluin-Nelemans, K Ohnishi, JL Steegmann, J Thaler. The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha. Haematologica 2005;90(3):335-340; https://doi.org/10.3324/%x.